14 episodes

Blood cancers are complex and multifaceted diseases, requiring knowledge by healthcare professionals on the array of diagnostic tests, treatment therapies, and survivorship issues. The LLS Podcast Series for Professionals provides up to date and accurate information on diagnosis, treatment and survivorship to educate HCPs treating patients with blood cancer. Listen in as we speak with experts who will guide us in understanding these topics, as well as address the importance of clinical trials, side effects management, and other concerns.

Treating Blood Cancers The Leukemia & Lymphoma Society

    • Science
    • 4.8 • 4 Ratings

Blood cancers are complex and multifaceted diseases, requiring knowledge by healthcare professionals on the array of diagnostic tests, treatment therapies, and survivorship issues. The LLS Podcast Series for Professionals provides up to date and accurate information on diagnosis, treatment and survivorship to educate HCPs treating patients with blood cancer. Listen in as we speak with experts who will guide us in understanding these topics, as well as address the importance of clinical trials, side effects management, and other concerns.

    Supporting LGBTQI Cancer Patients

    Supporting LGBTQI Cancer Patients

    Matthew B. Schabath, PhD, Moffitt Cancer Center, Tampa, FL















    Recorded on November 2, 2020





    Individuals in the LGBTQI community face many barriers in accessing healthcare. In this episode, Dr. Matthew Schabath from the Moffitt Cancer Center addresses ways healthcare professionals can be more competent in supporting persons within this community. Dr. Schabath breaks down the terminology and stakeholders within this group to help make conversations comfortable and more productive with patients and their caregivers, discusses an overview of COLORS training and its importance, and describes how best to include caregivers and loved ones in patient care. Join this important conversation today!

    Matthew B. Schabath, PhD

    Associate Member in Cancer Epidemiology

    Moffitt Cancer Center

    Tampa, FL

    • 27 min
    A Deeper Dive into MRD: A Conversation with Gail Roboz, MD

    A Deeper Dive into MRD: A Conversation with Gail Roboz, MD

    Gail J. Roboz, MD, Weill Cornell Medical College, New York, NY















    Recorded on October 2, 2020





    Minimal/measurable residual disease (MRD) refers to the small number of cancer cells that remain in the body after treatment. In this episode, Gail Roboz, MD, from Weill Cornell Medical College, provides an overview of MRD, including understanding its definition, explains the role advancements in technology have played in detection, and underscores the importance of understanding to what degree this detection can be helpful. Dr. Roboz provides strategies to communicate with patients about the impact of MRD on prognosis, treatment and outcomes and discusses the future of MRD testing in blood cancers. Tune in today!

    Gail J. Roboz, MD

    Director, Clinical and Translational Leukemia Programs

    Professor of Medicine

    Weill Cornell Medical College

    The New York Presbyterian Hospital New York, NY





    This podcast episode is supported by Amgen.

    • 45 min
    Communicating with Caregivers: Strategies for HCPs

    Communicating with Caregivers: Strategies for HCPs

    Allison J. Applebaum, Ph.D., Memorial Sloan Kettering Cancer Center, New York, NY















    Recorded on June 26, 2020





    Caregivers of patients diagnosed with cancer often don’t allow themselves to connect to the negative emotions that arise. Discussion with Dr. Allison Applebaum focuses on the importance of coaching caregivers to ask for help, problem solve, formulate questions to ask the oncologist, have potentially challenging conversations with their loved one, and to receive professional and peer support. As Dr. Applebaum states, the simplest and most powerful intervention a healthcare professional can do is to ask the caregiver, whether in person or via telehealth, “How are you doing and what can I do to support you?” Tune in for strategies and an interesting discussion.

    Allison J. Applebaum, Ph.D.

    Assistant Attending Psychologist

    Director, Caregivers Clinic

    Department of Psychiatry & Behavioral Sciences

    Memorial Sloan Kettering Cancer Center New York, NY

    • 32 min
    Communicating with the Young Adult with Blood Cancer

    Communicating with the Young Adult with Blood Cancer

    Carma Bylund, PhD, FACH, and Carla Fisher, PhD















    Recorded on August 13, 2020





    Young adults (YAs) are navigating physical, cognitive, and psychological changes, and transitioning into a more independent time of their life including social life and making more decisions on their own. They often grapple with unique issues when faced with a cancer diagnosis. Carma Bylund, PhD, FACH and Carla Fisher, PhD discuss how best to communicate with these young adults. They describe techniques and tips for caregivers and HCPs (e.g. PACES model), and discuss topics such as fertility, intimacy, sexuality, LGBTQ specific needs, and how to encourage YAs to be involved in the decision making process for their care.







    Carma Bylund, PhD, FACHProfessorCollege of Journalism and CommunicationsCollege of MedicineUF Health Cancer Center, University of FloridaGainesville, FL











    Carla Fisher, PhDAssociate ProfessorCollege of Journalism and CommunicationsUF Health Cancer Center, University of FloridaGainesville, FL

    • 32 min
    Facilitating the Learning Experience of Children and AYAs During and After Cancer Treatment

    Facilitating the Learning Experience of Children and AYAs During and After Cancer Treatment

    Nicole Gutman, MS, and Mary Kay Irwin, EdD















    Recorded on May 19, 2020





    Children, adolescents, and young adults (AYAs) face unique challenges when returning to school during or after cancer treatment. In this episode, Nicole Gutman, MS, a School Intervention Consultant, and Mary Kay Irwin, EdD, Director of School Health, at Nationwide Children’s Hospital, describe the psychosocial, educational, and cognitive effects cancer has on a child/AYA, their parents, siblings, and classmates. They discuss age appropriate interventions to assist families, address strategies to help meet the students’ needs, review laws that protect pediatric cancer survivors’ rights, and identify resources to support families and school personnel.







    Nicole Gutman, MSSchool Intervention Consultant











    Mary Kay Irwin, EdDDirector of School HealthNationwide Children’s Hospital

    • 34 min
    Myelodysplastic Syndromes (MDS): Caring for Low and High-Risk Patients

    Myelodysplastic Syndromes (MDS): Caring for Low and High-Risk Patients

    James M. Foran, MD, FRCPC, Mayo Clinic Cancer Center, Jacksonville, FL















    Recorded on May 28, 2020





    Listen in as Dr. James Foran from Mayo Clinic defines MDS, discusses the diagnostic workup and factors used to develop a treatment plan, including the importance of the morphology of the bone marrow and the blast count, cytogenetics and next generation sequencing and patient management strategies for low and high-risk MDS. The conversation continues with potentially exciting treatment options being studied in clinical trials, the impact of COVID-19 on caring for patients with MDS, and the involvement of the entire healthcare team.

    James M. Foran, MD, FRCPC

    Consultant & Associate Professor

    Division of Hematology & Medical Oncology

    Mayo Clinic Cancer Center Jacksonville, FL

    • 37 min

Customer Reviews

4.8 out of 5
4 Ratings

4 Ratings

Top Podcasts In Science

Listeners Also Subscribed To